Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England

Developmental Medicine and Child Neurology

Volumn 56, Issue 11, 2014, Pages 1117-1123

  Winstone, Anne Marie ^a   Stellitano, Lesley ^a   Verity, Christopher ^a   Andrews, Nick ^b   Miller, Elizabeth ^b   Stowe, Julia ^b   Shneerson, John ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGICAL ADJUVANT; IMMUNOLOGICAL ADJUVANT AS03; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; ADOLESCENT; ADULT; AGGRESSION; ARTICLE; ATAXIA; AUTOMATISM; BEHAVIOR DISORDER; CATAPLEXY; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DAYTIME SOMNOLENCE; FAMILY HISTORY; FEMALE; FLU LIKE SYNDROME; GENERAL PRACTITIONER; HALLUCINATION; HEADACHE; HUMAN; HYPNAGOGIC HALLUCINATION; HYPNOPOMPIC HALLUCINATION; INCONTINENCE; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; LEARNING DISORDER; LEG CRAMP; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL INSTABILITY; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; NARCOLEPSY; NEUROLOGIST; NIGHTMARE; PARASOMNIA; PRIORITY JOURNAL; PTOSIS; QUESTIONNAIRE; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; SLEEP DISORDER; SLURRED SPEECH; SNORING; TONGUE DISEASE; UNITED KINGDOM; WEIGHT GAIN; EPIDEMIOLOGY; FACE MUSCLE; MEDICAL RECORD; PATHOPHYSIOLOGY; PRESCHOOL CHILD; TONGUE; VACCINATION; VIROLOGY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; ENGLAND; FACIAL MUSCLES; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MEDICAL RECORDS; MUSCLE HYPOTONIA; NARCOLEPSY; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TONGUE; VACCINATION;

EID: 84914105236     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.12522     Document Type: Article

References (28)

1. Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 2012; 7: e33536.
2. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS ONE 2012; 7: e33723.
3. Szakacs A, Darin N, Hallbook T. Increased childhood incidence of narcolepsy in western Sweden after H1NI influenza vaccination. Neurology 2013; 80: 1315-21.
4. Department of Health, Salisbury D, Ramsay M (eds.) Immunisation Against Infectious Disease. London: Stationery Office, 2006: 193-4. www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_079917 (accessed 14 August 2012).
5. Chief Medical Officer's Update. (2009) The H1N1 Swine Flu Vaccination Programme. Department of Health. www.dh.gov.uk/en/Publicationsandstatistics/Lettersandcirculars/Dearcolleagueletters/DH_107169 (accessed 19 July 2012).
6. Department of Health. (2009) Extension of the Swine Flu Vaccination Programme. Department of Health. http://webarchive.nationalarchives.gov.uk/+/www.dh.gov.uk/en/Publichealth/Flu/Swineflu/InformationandGuidance/Vaccinationprogramme/DH_108850 (accessed 9 October 2013).
7. Department of Health. (2010) Pandemic H1N1 (Swine) Influenza Vaccine Uptake Amongst Patient Groups in Primary Care in England 2009/10, DH/HPA. www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_121014.pdf (accessed 9 October 2013).
8. Miller E, Andrews N, Stellitano L, et al. Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ, 2013; 346: f794. doi: 10.1136/bmj.f794.
9. Hospital Episode Statistics. National Health Service (NHS). www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937 (accessed 9 August 2013).
10. World Health Organization. International Statistical Classification of Diseases and Related Problems, 10th Revision. Geneva: WHO, 2010.
11. American Academy of Sleep Medicine. International Classification of Sleep Disorders: Diagnostic and Coding Manual. 2nd edn. Westchester, IL: American Academy of Sleep Medicine, 2005.
12. National Narcolepsy Study Steering Committee. Investigation of an Increase in the Incidence of Narcolepsy in Children and Adolescents in 2009 and 2010. http://healthupdate.gov.ie/wpcontent/uploads/2012/04/Final_Report_of_National_Narcolepsy_Study_Steering_Committee-latest1.pdf (accessed 6 August 2012).
13. Heier MS, Gautvik KM, Wannag E, et al. Incidence of narcolepsy in Norwegian children and adolescents after vaccination against H1N1 influenza A. Sleep Med 2013. Published online 17 July 2013 and http://dx.doi.org/10.1016/j.sleep.2013.03.020 (accessed 21 August 2013).
14. Dauvilliers Y, Arnulf I, Lecendreux M, et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 2013; 136: 2486-96.
15. Choe Y, Bae G-R, Lee D-H. No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study. Vaccine 2012; 30: 7439-42.
16. European Centre for Disease Prevention and Control. Narcolepsy in Association with Pandemic Influenza Vaccination: A Multi-Country European Epidemiological Investigation. Stockholm: ECDC, 2012.
17. Melén K, Partinen M, Tynell J, et al. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. PLoS ONE 2013; 8: e68402.
18. Han F, Lin L, Warby SC, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Ann Neurol 2011; 70: 410-7.
19. Guilleminault C, Mignot E, Grumet FC. Familial patterns of narcolepsy. Lancet 1989; 334: 1376-9.
20. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 50: S16-22.
21. Dauvilliers Y, Maret S, Bassetti C, et al. A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1. Neurology 2004; 62: 2137-8.
22. Plazzi G, Pizza F, Palaia V, et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011; 134: 3477-89.
23. Poli F, Overeem S, Lammers GJ, et al. Narcolepsy as an adverse event following immunisation: case definition and guidelines for data collection, analysis and presentation. Vaccine 2013; 31: 994-1007.
24. Gonzalez-Galarza F, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011; 39: D913-9.
25. Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000; 355: 39-40.
26. Mignot E, Nishino S. Pathophysiological and pharmacologic aspects of the sleep disorder narcolepsy. In: Davis KL, Charney D, Coyle JT, Neneroff C, editors. Neuropsychopharmacology: The Fifth Generation of Progress. Chapter 131. Philadelphia, PA: Lippincott Williams and Wilkins, 2002: 1907-21.
27. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002; 59: 1553-62.
28. De la Herrán-Arita AK, Kornum BR, Mahlios J, et al. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. Sci Transl Med 2013; 5: 1-13.